Cargando…
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV
While antiretroviral therapy (ART) can completely suppress viremia, it is not a cure for HIV. HIV persists as a latent reservoir of infected cells, able to evade host immunity and re-seed infection following cessation of ART. Two promising immunotherapeutic strategies to eliminate both productively...
Autores principales: | Powell, Allison B., Ren, Yanqin, Korom, Maria, Saunders, Devin, Hanley, Patrick J., Goldstein, Harris, Nixon, Douglas F., Bollard, Catherine M., Lynch, Rebecca M., Jones, R. Brad, Cruz, Conrad Russell Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508916/ https://www.ncbi.nlm.nih.gov/pubmed/33005704 http://dx.doi.org/10.1016/j.omtm.2020.08.015 |
Ejemplares similares
-
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
por: Powell, Allison B., et al.
Publicado: (2019) -
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV
por: Ghofrani, Joshua, et al.
Publicado: (2023) -
Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression
por: Wilson, Andrew, et al.
Publicado: (2021) -
Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014) -
HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform
por: Patel, Shabnum, et al.
Publicado: (2019)